These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19406185)

  • 1. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial c-di-GMP is an immunostimulatory molecule.
    Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F
    J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice.
    Xu H; Hu C; Gong R; Chen Y; Ren N; Xiao G; Xie Q; Zhang M; Liu Q; Guo A; Chen H
    Clin Vaccine Immunol; 2011 Jun; 18(6):893-900. PubMed ID: 21508165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
    Mirshekar M; Haghighat S; Mousavi Z; Abdolghaffari AH; Yazdi MH
    Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity.
    Haghighat S; Siadat SD; Rezayat Sorkhabadi SM; Akhavan Sepahi A; Sadat SM; Yazdi MH; Mahdavi M
    Microb Pathog; 2017 Jul; 108():32-39. PubMed ID: 28457901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
    Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
    Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.
    Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A
    Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
    Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
    Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.
    Nour El-Din AN; Shkreta L; Talbot BG; Diarra MS; Lacasse P
    Vaccine; 2006 Mar; 24(12):1997-2006. PubMed ID: 16426711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a Staphylococcus aureus-cholera toxin A
    Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
    Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.
    Hu DL; Cui JC; Omoe K; Sashinami H; Yokomizo Y; Shinagawa K; Nakane A
    Infect Immun; 2005 Jan; 73(1):174-80. PubMed ID: 15618152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Begier E; Seiden DJ; Patton M; Zito E; Severs J; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
    Vaccine; 2017 Feb; 35(8):1132-1139. PubMed ID: 28143674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
    Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
    Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.
    Ogunniyi AD; Paton JC; Kirby AC; McCullers JA; Cook J; Hyodo M; Hayakawa Y; Karaolis DK
    Vaccine; 2008 Aug; 26(36):4676-85. PubMed ID: 18640167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clumping factor A binding region A in a subunit vaccine against Staphylococcus aureus-induced mastitis in mice.
    Gong R; Hu C; Xu H; Guo A; Chen H; Zhang G; Shi L
    Clin Vaccine Immunol; 2010 Nov; 17(11):1746-52. PubMed ID: 20826613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.
    Sun H; Wei C; Liu B; Jing H; Feng Q; Tong Y; Yang Y; Yang L; Zuo Q; Zhang Y; Zou Q; Zeng H
    Int J Nanomedicine; 2015; 10():7275-90. PubMed ID: 26664118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
    Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
    Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
    Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.